Plainly and simply, any company who communicates to the public should have a Public Relations or Communications department - or at the very least, a paid consultant or an agency of record. Not only do those people strategize the communications policies and schedules, they know how to write from the lens of putting the company best-foot-forward in an understandable, translational and concise manner. They also know how to media-train their execs who may be consumer-facing on live television. They also have longstanding media relationships they can leverage on behalf of their clients. Not that deep. It's one of the most important investments that Cydodyn could make.
agreed Saltz.! Everything counts at this level and BOD and NP need to bring their “A” game. It has been acknowledged that big pharma does not want CYDY to succeed And the company does not need to help them by providing ammunition to discredit management. The little things matter and the PR matter was not a little thing. Remember the old line “ Fake it til you make it”? That means play the role where you want to be not where you are now. We want to be a big Nasdaq listed bio tech...is this how Amgen or Gilead rolls things out?